Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade

Experimental and Clinical Cardiology

Volumn 16, Issue 4, 2011, Pages 121-124

  Mak, I Tong ^a   Chmielinska, Joanna J ^a   Kramer, Jay H ^a   Spurney, Christopher F ^b   Weglicki, William B ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cardiac dysfunction; Hypomagnesemia; Neutral endopeptidase; Neutrophil activation; Oxidative stress; Substance P receptor blockade

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 8 ISOPROSTANE; GLUTATHIONE; MAGNESIUM; MEMBRANE METALLOENDOPEPTIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ERYTHROCYTE; HEART CONTRACTION; HEART DISEASE; HISTOCHEMISTRY; HYPOMAGNESEMIA; LEUKOCYTE; LEUKOCYTE ACTIVATION; MAGNESIUM DEFICIENCY; MALE; NEUTROPHIL; NONHUMAN; RAT;

EID: 80055108518     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dubey A, Solomon R. Magnesium, myocardial ischemia and arrhythmias: The role of magnesium in myocardial infarction. Drugs 1989;37:1-7. (Pubitemid 19050432)
2. Leary WP. Content of magnesium in drinking water and deaths from ischemic heart disease in white South Africans. Magnesium 1986;5:150-3.
3. Punsar S, Karvonen MJ. Drinking water quality and sudden death: Observations from west and east Finland. J Am Coll Nutr 1985;4:195-206.
4. Weglicki WB, Mak IT, Kramer JH, et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996;31:677-82. (Pubitemid 26175133)
5. Kramer JH, Spurney C, Iantorno M, et al. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009;338:22-7.
6. Mak IT, Dickens BF, Komarov AM, Phillips TM, Weglicki WB. Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency - modulation effect by NOS inhibition. Mol Cell Biochem 1997;176:35-9 (Pubitemid 27491463)
7. Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat. Magnesium Res 2003;16:91-7. (Pubitemid 37386923)
8. Mak IT, Kramer JH, Chmielinska JJ, Khalid H, Landgraf KM, Weglicki WB. Inhibition of neutral endopeptidase potentiates neutrophil activation during Mg-deficiency in the rat. Inflammation Res 2008;57:300-5.
9. Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Phillips TM. Neurogenic peptides and the cardiomyopathy of Mg-deficiency: Effects of substance P-receptor inhibition. Mol Cell Biochem 1994;130:103-9. (Pubitemid 24127581)
10. Tejero-Taldo MI, Kramer JH, Mak IT, Komarov AM, Weglicki WB. The nerve-heart connection in the prooxidant response to Mg-deficiency. Heart Fail Rev 2006;11:35-44. (Pubitemid 43986206)
11. Iwamoto I, Kimura A, Ochiai K, Tomioka H, Yoshida S. Distribution of NEP activity in human blood leukocytes. J Leuk Biol 1991;49:116-25.
12. Wick MJ, Buesing EJ, Wehling CA, et al. Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183:330-40.
13. Mak IT, Chmielinska JJ, Kramer JH, Weglicki WB. AZT-Induced cardiovascular toxicity - attenuation by Mg-supplementation. Cardiovascular Toxicol 2009;9:78-85.
14. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression of and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2006;65:1012-21. (Pubitemid 44521802)
15. Kuranstin-Mills J, Cassidy MM, Stafford RE, Weglicki WB. Marked alterations in circulating inflammatory cells during cardiomyopathy development in a Mg-deficient rat model. Br J Nutr 1997;78:845-55. (Pubitemid 27483026)
16. Kramer JH, Mak I T, Phillips TM, Weglicki WB. Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med 2003;228:665-73. (Pubitemid 37163256)
17. Weglicki WB, Dickens BF, Wagner TL, Chmielinska JJ, Phillips TM. Immunoregulation by neuropeptides in magnesium deficiency: Ex vivo effect of enhanced substance P production on circulating T lymphocytes from Mg-deficient mice. Magnes Res 1996;9:3-11. (Pubitemid 126478602)
18. Weglicki WB, Mak IT, Chmielinska JJ, Tejero-Taldo MI, Komarov A, Kramer JH. The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res 2010;23:1-8.
19. Jurjus AR, Walsh RJ, Weglicki WB, Correa-de-Araujo R. Increase in the expression of substance P receptors in the atria of Mg-deficient rats. Cardiovasc Pathobiol 1998;2:199-206.
20. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg-deficiency by substance P receptor inhibition. Circ Res 1994;24:1009-13.
21. Shinall H, Song ES, Hersh LB. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: A potential Alzheimer's disease spiral. Biochemistry 2005;44:15345-50. (Pubitemid 41681468)
22. Kanazawa H, Hirata K, Yoshikawa J. Administration of SIN-1 induces guinea pig airway hyperresponsiveness through inactivation of airway neutral endopeptidase. Int Arch Allergy Immunol 1999;120:317-22. (Pubitemid 30009025)
23. Mak IT, Komarov AM, Wagner TL, Stafford RE, Dickens BF, Weglicki WB. Enhanced nitric oxide production during Mg-deficiency and its role in mediating red cell glutathione loss. Am J Physiol 1996;271:C385-90. (Pubitemid 26298815)
24. Weglicki WB, Chmielinska JJ, Tejero-Taldo MI, et al. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 2009;22:167S-73S.